Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2' O Methyluridine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107522763B reveals a high-yield route for Sofosbuvir intermediate VII, eliminating chromatography and reducing costs for pharmaceutical manufacturers.
Patent CN114369124A reveals a novel 4-step synthesis for 2'-substituted pyrimidine nucleosides, offering high purity and scalable manufacturing for nucleic acid drugs.
Patent CN106188193A reveals a novel N-protection strategy for Sofosbuvir intermediates, ensuring high purity, reduced impurities, and scalable manufacturing for global supply chains.
Novel patented route for high-purity nucleoside intermediates. Enhances solubility and yield for nucleic acid drug manufacturing supply chains.
Patent CN106565805B reveals a cost-effective D-ribose route for Sofosbuvir, offering reliable supply chain solutions and reduced manufacturing complexity for global pharmaceutical buyers.